Back to Research Home
HSICHenry Schein Inc
Health Care · Health Care Distributors · Large
$84.96−1.21%
As of 23 Oct 2026Mkt cap $10.1B
Stage 13
AVOID
Fundamentals
39.0/75
Technical
6.5/15
Independent
45.4/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- −0.7%
- 3M
- +0.4%
- 6M
- +9.6%
- 1Y
- +33.8%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 24.8xHist median 23.1x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 18.2x
- FCF yield
- 5.5%
Quality
- ROIC
- 8.5%
- Operating margin
- 5.0%
- FCF margin
- 4.3%
- Current ratio
- 1.4x
Growth
- Revenue growth
- +4.0%Latest FY YoY
- Revenue CAGR
- +1.5%
- EPS CAGR
- −7.4%
- FCF CAGR
- −2.4%
Capital
- Share-count trend
- −3.9%3Y annualised
- Net debt
- $2.2B3.0x OCF
Annual trend
- CAGR 2021–2025
- +1.5%
- Latest · 2025
- $13B
- YoY
- +4.0%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-03
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded